Sustainability & Climate

Dr. Toyin Ajayi's board appointment signals a major strategic move to integrate nutrition into healthcare for America's most vulnerable populations.

JenaValve's Trilogy system gains historic FDA approval, offering a new, minimally invasive option for high-risk patients with a life-threatening heart condition.

CareCloud unveils its next-gen MAP App, blending AI with trusted HFMA benchmarks to help hospitals navigate complex financial challenges and boost efficiency.

Private equity firm Manna Tree hires Jennifer Roach as Managing Director, signaling a major play to dominate the booming consumer health and wellness market.

A new US-Canadian partnership between UNION and NALAGX aims to use software-driven factories to solve the critical 155mm artillery shell shortage.

New data on 1.3 million trips shows Orlando and Cancun are top spots, but rising costs and global risks are reshaping how Americans plan their getaways.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

A landmark deal between Australia's VVMF and UK's OXB aims to create a new cell and gene therapy manufacturing hub for the booming Asia-Pacific market.

A new partnership will leverage genetically engineered mice to create novel antibody drugs, potentially unlocking treatments for cancer and brain diseases.

A new report shows Washington charter school alumni earn more and own homes at higher rates, but small sample sizes spark a debate on the data's weight.

With a 17x speed boost from NVIDIA, Dexterity's Physical AI is now loading trucks at FedEx, signaling a new era for automated supply chains.

A new report reveals security teams are drowning in alerts, wasting time on manual work while 79% of threats are found by outsiders first. Is AI the answer?

With a new CEO and Chair, IsomAb is advancing a disease-modifying drug for 9 million angina patients, eyeing a major Series A fundraise.

Amid a historic overhaul, Kimberly-Clark's eighth straight ethics award signals that integrity is not just a policy, but a core business strategy.

A new partnership seeks to conquer C. difficile, a deadly hospital infection that has stumped pharma giants, by advancing a novel dual-action vaccine.

The strategic divestment to Blue Moon Metals highlights Liberty Gold's pivot to its core gold assets and a broader mining trend of portfolio specialization.

New preclinical data reveals a novel gene therapy that not only kills tumor cells but also boosts immunity, offering hope against drug-resistant lung cancer.

Residents gain new choices for hurricane and energy upgrades as state and federal reforms aim to make popular PACE financing safer for homeowners.

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.

By eliminating student fees, TutorABC's expanded service with 700+ universities makes global education more accessible but also spotlights industry debates.